Pegcetacoplan treatment for geographic atrophy due to age-related macular degeneration: a plain language summary of the FILLY study

A new plain language summary in the journal Immunotherapy summarises the results of the FILLY study. This study looked at the investigational therapy pegcetacoplan for geographic atrophy due to age-related macular degeneration.

Read the summary here.

The original article on which this summary is based is called ‘Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial’ and was originally published in the journal Ophthalmology. The original article can be read here.

• age-related macular degeneration
• FILLY
• geographic atrophy
• pegcetacoplan
• treatment emergent adverse events